[
  {
    "ts": null,
    "headline": "Why Vertex Pharmaceuticals Continues To Outperfrom",
    "summary": "Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the importance of Q2 2025 earnings.",
    "url": "https://finnhub.io/api/news?id=2661aaa4ff891c6c9080954d0e4225fe6b1d63dedcd02f264903cb3f540b80d7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752398500,
      "headline": "Why Vertex Pharmaceuticals Continues To Outperfrom",
      "id": 135909812,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/827151642/image_827151642.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the importance of Q2 2025 earnings.",
      "url": "https://finnhub.io/api/news?id=2661aaa4ff891c6c9080954d0e4225fe6b1d63dedcd02f264903cb3f540b80d7"
    }
  }
]